The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, yet its legacy within the broader industry now raises questions about future returns . Copycat versions are diminishing market share, prompting worries that betting on companies heavily reliant to Viagra's previous influence could be a dangerous move ,